Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1631 1633 1634 1651
This examiner grants 67% of resolved cases
Jennifer Suzanne Spence examines applications in Tech Center 1600 and Art Unit 1631, with 128 resolved cases. The allowance rate of 66.4% suggests a moderate to high probability of success. However, the median days to allowance of 1339 indicates that the process is relatively slow for those who do achieve a grant. The 128 resolved cases provide a reliable view of this examiner's tendencies.
The interview lift of 47.5% is a very strong indicator of the value of direct communication. This lift significantly enhances the 66.4% base allowance rate, making an interview a highly recommended step in the prosecution process. For the 128 resolved cases, the 47.5% lift shows that the examiner is very responsive to verbal arguments. Practitioners should use this tool to navigate the 1339 days of pendency and secure an allowance more efficiently. The data from Art Unit 1631 suggests that while the base rate is 66.4%, the interview is the most effective way to ensure a positive outcome. Direct interaction is a key strategic advantage.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18850219 | SINGLE-STRAND FORM POLYNUCLEOTIDE AND USE THEREOF IN GENOME EDITING | Non-Final OA | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY |
| 17640281 | CHIMERIC ANTIGEN RECEPTORS AND RELATED METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18716634 | COMPOSITIONS AND METHODS FOR PRODUCTION AND USE OF A SCALABLE HUMAN CELL-DERIVED EXTRACELLULAR MATRIX | Non-Final OA | Ohio State Innovation Foundation |
| 18017139 | M13 BACTERIOPHAGE WITH A HIGH CYSTEINE CONTENT AND GENETICALLY ENGINEERABLE HYDROGELS | Final Rejection | Massachusetts Institute of Technology |
| 17272126 | ENGINEERED REGULATORY T CELL | Final Rejection | KING'S COLLEGE LONDON |
| 18249339 | AN ADHERENT CELL CULTURE METHOD FOR GENERATING TIGHT JUNCTION BETWEEN CELLS AND ITS PRODUCT APPLICATION | Final Rejection | ZHEJIANG UNIVERSITY |
| 18182377 | METHOD FOR BUILDING CO-CULTURE MODEL FOR CACO-2/RAW-264.7 CELLS INDUCED BY LIPOPOLYSACCHARIDES AND APPLICATION OF CO-CULTURE MODEL | Final Rejection | ZHEJIANG UNIVERSITY OF TECHNOLOGY |
| 17756116 | LARGE-SCALE COMBINED CAR TRANSDUCTION AND CRISPR GENE EDITING OF MSC CELLS | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17661057 | IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17633294 | ANTI-VIRAL CENTRAL MEMORY CD8+ VETO CELLS IN HAPLOIDENTICAL STEM CELL TRANSPLANTATION | Non-Final OA | Board of Regents, The University of Texas System |
| 18690946 | PIG EMBRYO-DERIVED PLURIPOTENT STEM CELLS AND USE THEREOF | Non-Final OA | CHINA AGRICULTURAL UNIVERSITY |
| 18178736 | METHODS AND MICROFLUIDIC DEVICE FOR PRODUCING EXTRACELLULAR VESICLES | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18722500 | PSEUDOTYPED LENTIVIRAL VECTORS | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18021475 | METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO ECTODERMAL, MESODERMAL, AND ENDODERMAL CELLS | Non-Final OA | TOSOH CORPORATION |
| 18266689 | DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES | Final Rejection | AMGEN INC. |
| 18516243 | NANOPARTICLES AND BIOTEMPLATES WITH TUNABLE LENGTH AND METHODS OF MANUFACTURING THE SAME | Non-Final OA | University of Delaware |
| 18851534 | ADENO-ASSOCIATED VIRUS VECTORS FOR NUCLEIC ACID DELIVERY TO RETINAL CELLS | Non-Final OA | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION |
| 16482420 | ENGINEERING BLOOD VESSEL CELLS FOR TRANSPLANTATION | Non-Final OA | CORNELL UNIVERSITY |
| 18824380 | METHOD FOR DIFFERENTIATION OF OCULAR CELLS AND USE THEREOF | Non-Final OA | FUJIFILM Cellular Dynamics, Inc. |
| 18787160 | Compositions and Methods for Producing Megakaryocytes | Non-Final OA | Stellular Bio, Inc. |
| 18673148 | FUNCTIONALIZED WELL PLATE, METHODS OF PREPARATION AND USE THEREOF | Final Rejection | Bruker Spatial Biology, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy